Comparison 3. Nandrolone decanoate versus EPO.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Haemoglobin	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
2 Haematocrit	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
3 Plasma total protein	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
4 Prealbumin	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
5 Transferrin	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
6 Serum albumin	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
7 Kidney function	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
7.1 BUN [mg/dL]	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
7.2 SCr [mg/dL]	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
8 Adverse effects	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected